Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Vascular by Year
Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Net Sales ($M) ($M)
Stryker Vascular: $1,968M in FY2025, up 50.6% from a year earlier.
Latest, FY2025
1,968
Period ended Dec 31, 2025
Change on a year earlier
+50.6%
1,307 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below
Where the FY2025 figure comes from
Renamed from Neurovascular to Vascular in 2025 following the February 2025 acquisition of Inari Medical (Peripheral Vascular).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,968 | +50.6% | ir|change_in_pres_2026Q1 ↗ |
| FY2024 | Dec 31, 2024 | 1,307 | +6.6% | ir|change_in_pres_2026Q1 ↗ |
| FY2023 | Dec 31, 2023 | 1,226 | +2.2% | ir|change_in_pres_2026Q1 ↗ |
| FY2022 | Dec 31, 2022 | 1,200 | +1.0% | 0000310764-23-000005|sykex991earningsq42022.htm ↗ |
| FY2021 | Dec 31, 2021 | 1,188 | +22.1% | 0000310764-22-000008|sykex991earningsq42021.htm ↗ |
| FY2020 | Dec 31, 2020 | 973 | +5.3% | 0000310764-22-000008|sykex991earningsq42021.htm ↗ |
| FY2019 | Dec 31, 2019 | 924 | – | 0000310764-22-000028|syk-20211231.htm ↗ |
Breakdown
What makes up vascular
- Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Constant Currency Sales Growth YoY (%)50.0% · FY2025
- Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Reported Sales Growth YoY (%)50.6% · FY2025
- Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — U.S. Net Sales ($M)1,048 · FY2025
- Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — International Net Sales ($M)920 · FY2025
Cite this data
StockData. (2026). Stryker Vascular ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-vasc-ww-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.